首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1471952

不孕不育檢測市場規模和預測、全球和地區佔有率、趨勢和成長機會分析報告範圍：按類型、檢測試劑盒、樣本、最終用戶和地理位置

Infertility Testing Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Test Kits, Sample, End User, and Geography

出版日期: 2024年03月04日 | 出版商:

The Insight Partners | 英文 150 Pages | 商品交期: 1-5個工作天內

價格

簡介目錄

依據「2028 年不孕症檢測市場預測- COVID-19 影響和全球分析- 按類型、檢測套件、樣本和最終用戶、地理位置」的新研究，預計市場規模將從2022 年的4.242 億美元成長到2030年達到8.2008億美元；預計 2022-2030 年複合年成長率為 8.6%。市場成長歸因於男性和女性不孕症病例的增加以及不孕症檢測的不斷進步。不斷加強的宣傳活動可能為不孕症檢測市場提供成長機會。然而，缺乏對不孕症檢測試劑盒的認知和限制阻礙了高壓氧治療市場的成長。

根據 Elsevier BV 發表的一項題為「生育與不孕症：定義與流行病學」的研究，已知不孕症影響著全世界約 8-12% 的夫婦。由於現代生活方式、疾病、生育延遲等多種原因，這一比例正逐漸增加。在男性生殖系統中，不孕最常見的原因是精液射出問題、精子缺失或少量、或精子的形狀（形態）和運動（活力）異常。對女性來說，不孕症可能是由子宮、卵巢、輸卵管和內分泌系統異常引起的。

2022年，北美在全球不孕症檢測市場中佔據主要佔有率。該地區市場成長的推動因素包括不孕症發生率高、男性和女性對不孕症檢測意識的提高、受多囊性卵巢症候群影響的女性人口不斷增加、女性首次懷孕年齡的上升以及不孕不育檢測試劑盒的容易取得透過電子商務網站。此外，生活方式的改變以及導致男性和女性不孕症和婦科疾病的不健康飲食趨勢的增加也是不孕症檢測市場成長的原因。此外，排卵監測儀的技術進步正在推動該地區的市場成長。此外，吸菸和菸草消費的增加將導致不孕症病例增加，從而推動市場成長。女性對自我測試和遠端監控測試的需求不斷成長以及新產品的創新預計將創造有利可圖的市場機會。

不斷增強的意識活動推動了不孕症檢測市場的成長機會

傳統上，夫妻之間的懷孕問題被歸咎於女性不孕。然而，現代人類科學和深入研究已經導致社會恥辱的轉變，人們開始關注男性不孕症。最近，男性正在接受測試並開始了解導致不孕症的因素。儘管世界某些地區的情況正在改善，但不同地區和地區仍然不知道新的檢測和治療方案以及病情的可用性。

這為組織和公司提供了舉辦和組織宣傳活動的機會，以闡明全球很大一部分男性面臨的這個敏感但重要的問題。例如，2020 年 11 月，Nova IVF Fertility 與《印度時報》合作發起了一場名為「生育對話」的運動，舉辦社交聚會，並與該領域的專家討論男性和女性之間的不孕問題。此外，庫柏外科公司(Cooper Surgical) 旗下的庫柏基因公司(Cooper Genomics) 發起了全國不孕不育意識週：不孕不育揭秘活動，教育普通民眾了解不孕不育的影響，並讓患者了解該公司提供的產品和服務，以增強全球家庭的能力。因此，適當的宣傳活動預計將為公司提供強大的展示平台，從而提供成長機會，在動態生態系統中推動收入。

基於類型的見解

根據類型，不孕症檢測市場分析是透過考慮以下細分市場進行的：男性和女性。到 2022 年，女性不孕症檢測領域將佔據更大的市場佔有率。

女性生育率下降、女性婦科問題日益普遍、職業女性忙碌的生活方式導致更大的壓力以及卵子數低是造成不孕症檢測市場佔有率高的主要因素。此外，許多女性不孕症測試的可用性有助於女性不孕症測試領域的市場成長。

基於測試套件的見解

依檢測試劑盒分類，不孕症檢測市場分為人類卵泡刺激素（FSH）檢測試劑盒、人類絨毛膜促性腺激素（HCG）檢測試劑盒、黃體生成素（LH）檢測試劑盒等。就收入而言，人類卵泡刺激素（FSH）檢測試劑盒細分市場在2022年主導不孕症檢測市場佔有率。

卵泡刺激素 (FSH) 檢測試劑盒有助於測量血液中 FSH 荷爾蒙的濃度。此測試通常用於評估男性和女性因各種原因（例如生育問題、更年期或性發育問題）的 FSH 水平。此外，先進的 FSH 生物相似藥產品、監管部門的批准、市場准入、 FSH 試劑盒生產的技術進步以及對有效避孕方案日益成長的需求預計將加速全球市場的成長。

基於最終用戶的見解

依最終用戶分類，不孕症檢測市場分為醫院和診所、生育中心和家庭護理。家庭護理領域在 2022 年佔據最大的市場佔有率，預計在預測期內複合年成長率最高為 9.0%。

領先企業正在實施擴張、合作、推出新產品和獲取新客戶群等策略，以挖掘目前的商機。

2023 年 8 月，Trajan Scientific and Medical 向 Fertilly 提供了 CE-IVD 註冊的 Mitra 設備。這家德國新創公司推出了歐洲首個使用乾血微量樣本和 VAMS 技術的家庭生育力測試套件。

2021 年 2 月，Fertility Focus 與 ExSeed Health（從事家庭精子檢測）合作，為計劃懷孕的人提供解決方案。

2020 年 6 月，Modern Fertility 推出了排卵和妊娠檢測試劑盒以及一款集中生育相關資料的行動應用程式。

2020 年 3 月，Proov 的家用排卵測試套件獲得 FDA 批准。

美國食品藥物管理局、疾病管制與預防中心 (CDC) 以及全球疾病負擔研究是準備不孕症檢測市場報告時參考的主要和次要來源。

歐洲
- 德國
- 法國
- 義大利
- 西班牙
- 英國
- 歐洲其他地區
亞太
- 澳洲
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 中東和非洲其他地區
南美洲和中美洲
- 巴西
- 阿根廷
- 南美洲和中美洲其他地區

第 12 章：產業格局

併購
協議、合作、合資企業
新產品發布
擴張和其他策略發展

第13章：競爭格局

關鍵參與者的熱圖分析
公司定位與專注

第 14 章：不孕症檢測市場 - 主要公司簡介

Merck KGaA
Procter & Gamble
bioMerieux SA
Alere Inc.
Babystart Ltd.
bioZhena Corporation
Quidel Corporation
SCSA Diagnostics, Inc.
CENTOGENE N.V.
Boditech Med Inc.

第 15 章：附錄

簡介目錄

Product Code: TIPHE100001421

According to our new research study on "Infertility Testing Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Type, Test Kits, Sample, and End User, Geography" the market is anticipated to grow from US$ 424.20 million in 2022 to US$ 820.08 million by 2030; it is estimated to register a CAGR of 8.6% during 2022-2030. Market growth is attributed to the increasing cases of infertility in men and women and growing advancements in infertility testing. Growing awareness campaigns will likely provide growth opportunities for the infertility testing market. However, the lack of awareness and limitations associated with infertility testing kits hinder the growth of the hyperbaric oxygen therapy market.

According to a study titled "Fertility and Infertility: Definition and Epidemiology," published in Elsevier B.V., infertility is known to affect around 8-12% of couples across the world. The proportion is gradually increasing due to several causes such as modern lifestyles, illnesses, and the postponement of parenthood. In the male reproductive system, infertility is most often caused by problems ejecting semen, missing or small amounts of sperm, or abnormal shape (morphology) and movement (motility) of sperm. In females, infertility can be caused by abnormalities associated with the uterus, ovaries, fallopian tubes, and endocrine system.

North America accounted for a major share of the global infertility testing market in 2022. The North American infertility testing market is segmented into the US, Canada, and Mexico. The market growth in this region is driven by the high occurrence of infertility, increasing awareness of infertility testing among men and women, the growing female population affected by PCOS, the rising age of first pregnancy among women, and the easy availability of infertility test kits through e-commerce websites. Also, changing lifestyles with increasing trends of unhealthy diets leading to infertility and gynecological disorders in men and women are responsible for the infertility testing market growth. Furthermore, technological advancements in ovulation monitors are bolstering the market growth in the region. Furthermore, the rising consumption of smoking and tobacco will lead to an increase in infertility cases, propelling the market growth. Growing demand for self-testing and remote monitoring testing among women and innovation of new products are expected to create profitable market opportunities.

Growing Awareness Campaigns Fuels the Infertility Testing Market Growth Opportunities

The pregnancy issues among couples have been traditionally blamed on females for being infertile. However, the modern age of human science and in-depth research and studies have led to a shift in the social stigma with a light on infertility among men. Recently, males are being tested and becoming aware of factors responsible for infertility. Although the scenario is improving in some regions of the world, various parts and geographies are still unaware of the availability of new testing and treatment options as well as the condition.

This provides organizations and companies opportunities to hold and organize awareness campaigns that shed light on this sensitive yet important issue faced by a significant percentage of males across the globe. For instance, in November 2020, Nova IVF Fertility in collaboration with the Times of India, initiated a movement called "Fertile Conversations" that hosted social meet-ups and discussions for infertility issues among males and females with experts in the field. In addition, Cooper Genomics, a Cooper Surgical company, launched the National Infertility Awareness Week: Infertility Uncovered campaign to educate the common people regarding the impact of infertility and well-aware patients regarding products and services available with the company to empower families worldwide. Thus, appropriate awareness campaigns are expected to provide robust showcasing platforms for companies, thereby offering growth opportunities to propel revenues within the dynamic ecosystem.

Type -Based Insights

Based on type, the infertility testing market analysis is carried out by considering the following segments: male and female. The female infertility testing segment held a larger market share in 2022. The male infertility testing segment is anticipated to register a higher CAGR of 9.2% during the forecast period.

Declining female fertility rates, increasing prevalence of gynecological issues in women, busier lifestyles of working women leading to more stress, and low egg counts are among the main factors responsible for the high infertility testing market share. Additionally, the availability of many female infertility tests contributes to the market growth for the female infertility testing segment.

Test Kits -Based Insights

By test kits, the infertility testing market is segmented into human follicular stimulating hormone (FSH) test kits, human chorionic gonadotropin (HCG) hormone test kits, luteinizing hormone (LH) test kits, and others. In terms of revenue, the human follicular stimulating hormone (FSH) test kits segment dominated the infertility testing market share in 2022. The highest CAGR of 9.2% is anticipated to be registered during the forecast period.

The follicular stimulating hormone (FSH) test kit helps measure the concentration of FSH hormone in the blood. The test is often used to assess FSH levels in men and women for various reasons such as fertility problems, menopause, or problems with sexual development. In addition, advanced biosimilar FSH products, regulatory approvals, market access, technological advances in FSH kit production, and a growing need for effective contraceptive options are predicted to accelerate global market growth.

End User -Based Insights

The infertility testing market, by end user, is categorized into hospitals & clinics, fertility centers, and homecare. The homecare segment held the largest market share in 2022 and is anticipated to register the highest CAGR of 9.0% during the forecast period.

Leading players are implementing strategies such as expansion, partnership, launch of new products, and acquiring a new customer base to tap prevailing business opportunities.

In August 2023, Trajan Scientific and Medical supplied CE-IVD registered Mitra devices to Fertilly. This German start-up launched Europe's first at-home fertility testing kits using dried blood micro samples with VAMS technology.

In February 2021, Fertility Focus partnered with ExSeed Health (which deals in at-home sperm testing) to provide solutions for those planning pregnancy.

In June 2020, Modern Fertility launched ovulation and pregnancy test kits and a mobile application to centralize fertility-related data.

In March 2020, Proov received FDA approval for its home ovulation test kit.

The US Food and Drug Administration, Centers for Disease Control and Prevention (CDC), and Global Burden of Disease Study are the primary and secondary sources referred to while preparing the infertility testing market report.

1. Introduction

1.1 Scope of the Study
1.2 Market Definition, Assumptions and Limitations
1.3 Market Segmentation

2. Executive Summary

2.1 Key Insights
2.2 Market Attractiveness Analysis

3. Research Methodology

4. Infertility Testing Market Landscape

4.1 Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain

5. Infertility Testing Market - Key Market Dynamics

5.1 Key Market Drivers
5.2 Key Market Restraints
5.3 Key Market Opportunities
5.4 Future Trends
5.5 Impact Analysis of Drivers and Restraints

6. Infertility Testing Market - Global Market Analysis

6.1 Infertility Testing - Global Market Overview
6.2 Infertility Testing - Global Market and Forecast to 2031

7. Infertility Testing Market - Revenue Analysis (USD Million) - By Type, 2021-2031

7.1 Overview
7.2 Female Infertility Testing
7.3 Male Infertility Testing

8. Infertility Testing Market - Revenue Analysis (USD Million) - By Test Kits, 2021-2031

8.1 Overview
8.2 Human Follicular Stimulating Hormone (FSH) Urine Test Kits
8.3 Human Chorionic Gonadotropin (HCG) Hormone Blood Test Kits
8.4 Luteinizing Hormone (LH) Test Kits
8.5 Others

9. Infertility Testing Market - Revenue Analysis (USD Million) - By Sample, 2021-2031

9.1 Overview
9.2 Blood
9.3 Urine
9.4 Others

10. Infertility Testing Market - Revenue Analysis (USD Million) - By End User, 2021-2031

10.1 Overview
10.2 Hospitals & Clinics
10.3 Fertility Centers
10.4 Homecare

11. Infertility Testing Market - Revenue Analysis (USD Million), 2021-2031 - Geographical Analysis

11.1 North America
- 11.1.1 North America Infertility Testing Market Overview
- 11.1.2 North America Infertility Testing Market Revenue and Forecasts to 2031
- 11.1.3 North America Infertility Testing Market Revenue and Forecasts and Analysis - By Type
- 11.1.4 North America Infertility Testing Market Revenue and Forecasts and Analysis - By Test Kits
- 11.1.5 North America Infertility Testing Market Revenue and Forecasts and Analysis - By Sample
- 11.1.6 North America Infertility Testing Market Revenue and Forecasts and Analysis - By End User
- 11.1.7 North America Infertility Testing Market Revenue and Forecasts and Analysis - By Countries
  - 11.1.7.1 United States Infertility Testing Market
    - 11.1.7.1.1 United States Infertility Testing Market, by Type
    - 11.1.7.1.2 United States Infertility Testing Market, by Test Kits
    - 11.1.7.1.3 United States Infertility Testing Market, by Sample
    - 11.1.7.1.4 United States Infertility Testing Market, by End User
  - 11.1.7.2 Canada Infertility Testing Market
    - 11.1.7.2.1 Canada Infertility Testing Market, by Type
    - 11.1.7.2.2 Canada Infertility Testing Market, by Test Kits
    - 11.1.7.2.3 Canada Infertility Testing Market, by Sample
    - 11.1.7.2.4 Canada Infertility Testing Market, by End User
  - 11.1.7.3 Mexico Infertility Testing Market
    - 11.1.7.3.1 Mexico Infertility Testing Market, by Type
    - 11.1.7.3.2 Mexico Infertility Testing Market, by Test Kits
    - 11.1.7.3.3 Mexico Infertility Testing Market, by Sample
    - 11.1.7.3.4 Mexico Infertility Testing Market, by End User

Note - Similar analysis would be provided for below mentioned regions/countries

11.2 Europe
- 11.2.1 Germany
- 11.2.2 France
- 11.2.3 Italy
- 11.2.4 Spain
- 11.2.5 United Kingdom
- 11.2.6 Rest of Europe
11.3 Asia-Pacific
- 11.3.1 Australia
- 11.3.2 China
- 11.3.3 India
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 Rest of Asia-Pacific
11.4 Middle East & Africa
- 11.4.1 South Africa
- 11.4.2 Saudi Arabia
- 11.4.3 U.A.E
- 11.4.4 Rest of Middle East & Africa
11.5 South & Central America
- 11.5.1 Brazil
- 11.5.2 Argentina
- 11.5.3 Rest of South & Central America

12. Industry Landscape

12.1 Mergers and Acquisitions
12.2 Agreements, Collaborations, Joint Ventures
12.3 New Product Launches
12.4 Expansions and Other Strategic Developments

13. Competitive Landscape

13.1 Heat Map Analysis by Key Players
13.2 Company Positioning and Concentration

14. Infertility Testing Market - Key Company Profiles

14.1 Merck KGaA
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments

Note - Similar information would be provided for below list of companies